Rockefeller Capital Management L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

  • $47.9 Billion
  • Q3 2025

A detailed history of Rockefeller Capital Management L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 25,842 shares of REGN stock, worth $17.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
25,842
Previous 29,620 12.75%
Holding current value
$17.9 Million
Previous $15.6 Million 6.56%
% of portfolio
0.03%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$534.91 - $598.71 $2.02 Million - $2.26 Million
-3,778 Reduced 12.75%
25,842 $14.5 Million
Q2 2025

Aug 08, 2025
SELL
$483.07 - $625.6 $18.4 Million - $23.8 Million
-37,988 Reduced 56.19%
29,620 $15.6 Million
Q1 2025

May 14, 2025
SELL
$634.14 - $744.83 $17.2 Million - $20.2 Million
-27,136 Reduced 28.64%
67,608 $42.9 Million
Q4 2024

Feb 13, 2025
SELL
$701.85 - $1046.91 $2.29 Million - $3.41 Million
-3,260 Reduced 3.33%
94,744 $67.5 Million
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $1.12 Million - $1.32 Million
-1,096 Reduced 1.11%
98,004 $103 Million
Q2 2024

Aug 12, 2024
SELL
$883.2 - $1071.19 $4.95 Million - $6 Million
-5,601 Reduced 5.35%
99,100 $104 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $821,447 - $903,948
-910 Reduced 0.86%
104,701 $101 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $1.24 Million - $1.41 Million
1,600 Added 1.54%
105,611 $92.8 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $17.5 Million - $21.4 Million
25,319 Added 32.17%
104,011 $85.6 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $2.26 Million - $2.68 Million
3,233 Added 4.28%
78,692 $56.5 Million
Q1 2023

May 17, 2023
SELL
$680.49 - $826.97 $18,373 - $22,328
-27 Reduced 0.04%
75,459 $62 Million
Q4 2022

Mar 06, 2023
SELL
$705.89 - $766.39 $3.83 Million - $4.16 Million
-5,424 Reduced 6.7%
75,486 $54.5 Million
Q3 2022

Nov 02, 2022
SELL
$573.97 - $724.32 $481,560 - $607,704
-839 Reduced 1.03%
80,910 $55.7 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $5.43 Million - $7.32 Million
-9,903 Reduced 10.81%
81,749 $48.3 Million
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $3.27 Million - $3.84 Million
5,492 Added 6.37%
91,652 $64 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $638,045 - $787,718
-1,174 Reduced 1.34%
86,160 $54.4 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $58.8 Million - $69.7 Million
-102,416 Reduced 53.97%
87,334 $52.9 Million
Q2 2021

Aug 10, 2021
BUY
$472.8 - $558.54 $29.5 Million - $34.9 Million
62,498 Added 49.11%
189,750 $106 Million
Q1 2021

May 11, 2021
BUY
$446.73 - $548.2 $8.32 Million - $10.2 Million
18,631 Added 17.15%
127,252 $60.2 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $1.93 Million - $2.46 Million
4,041 Added 3.86%
108,621 $52.5 Million
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $14.8 Million - $17.9 Million
-27,219 Reduced 20.65%
104,580 $58.5 Million
Q2 2020

Aug 12, 2020
SELL
$493.32 - $643.92 $1.34 Million - $1.75 Million
-2,710 Reduced 2.01%
131,799 $82.2 Million
Q1 2020

May 12, 2020
SELL
$336.18 - $494.43 $6.95 Million - $10.2 Million
-20,682 Reduced 13.33%
134,509 $65.7 Million
Q4 2019

Feb 07, 2020
SELL
$274.13 - $376.51 $22.4 Million - $30.8 Million
-81,823 Reduced 34.52%
155,191 $58.3 Million
Q3 2019

Nov 12, 2019
SELL
$273.46 - $318.39 $974,611 - $1.13 Million
-3,564 Reduced 1.48%
237,014 $65.7 Million
Q2 2019

Aug 09, 2019
BUY
$299.6 - $414.82 $29.8 Million - $41.3 Million
99,548 Added 70.59%
240,578 $75.3 Million
Q1 2019

May 10, 2019
SELL
$372.08 - $439.57 $554,771 - $655,398
-1,491 Reduced 1.05%
141,030 $57.9 Million
Q4 2018

Feb 12, 2019
SELL
$335.82 - $403.04 $10.8 Million - $13 Million
-32,249 Reduced 18.45%
142,521 $53.2 Million
Q3 2018

Nov 02, 2018
SELL
$351.14 - $408.51 $618,357 - $719,386
-1,761 Reduced 1.0%
174,770 $70.6 Million
Q2 2018

Jul 31, 2018
SELL
$284.6 - $344.99 $543,016 - $658,240
-1,908 Reduced 1.07%
176,531 $60.9 Million
Q1 2018

May 09, 2018
BUY
$315.82 - $393.78 $56.4 Million - $70.3 Million
178,439 New
178,439 $61.4 Million

Others Institutions Holding REGN

# of Institutions
1,508
Shares Held
86.6M
Call Options Held
2.38M
Put Options Held
1.61M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email